Myeloma Debate: Is MRD Ready for Prime Time? - No

Myeloma Debate: Is MRD Ready for Prime Time? - No

HMP CME

1 year
153 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Earn CME: https://naccme.com/program/7329 In this presentation from the 'Minimal Residual Disease (MRD) Testing in Multiple Myeloma' symposium at the 2019 Great Debates & Updates in Hematologic Malignancies in New York, Dr. Prashant Kapoor agues against using MRD as the primary treatment target for patients with multiple myeloma. © 2019 Imedex, an HMP Company
Up Next Autoplay